Evaluation of transdermal application of glipizide in a pluronic lecithin gel to healthy cats

American Journal of Veterinary Research

Volumn 66, Issue 4, 2005, Pages 581-588

  Bennett, Nicole ^c,d   Papich, Mark G ^a   Hoenig, Margarethe ^b   Fettman, Martin J ^c   Lappin, Michael R ^c  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c Department of Environmental and Radiological Health Sciences   (United States)

^d VCA Douglas County Animal Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIPIZIDE; GLUCOSE; INSULIN; PHOSPHATIDYLCHOLINE; POLOXAMER;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CAT; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; FEMALE; GEL; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; MALE; NONHUMAN;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; ANIMALS; BLOOD GLUCOSE; CATS; EXCIPIENTS; FEMALE; GLIPIZIDE; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PHOSPHATIDYLCHOLINES; POLOXAMER; RANDOM ALLOCATION;

ANIMALIA; FELIS CATUS;

EID: 17544382166     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2005.66.581     Document Type: Article

References (32)

1. Panciera DL, Thomas CB, Eicker SW, et al. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). J Am Vet Med Assoc 1990;197:1504-1508.
2. Lutz TA, Rand JS. Pathogenesis of feline diabetes mellitus. Vet Clin North Am Small Anim Pract 1995;25:527-552.
3. Appleton DJ, Rand JS, Sunvold GD. Insulin sensitivity decreases with obesity, and lean cats with low insulin sensitivity are at greatest risk of glucose intolerance with weight gain. J Feline Med Surg 2001;3:211-228.
4. Kirk CA, Feldman EC, Nelson RW. Diagnosis of naturally acquired type-I and type-II diabetes mellitus in cats. Am J Vet Res 1993;54:463-467.
5. Feldhahn JR, Rand JS, Martin G. Insulin sensitivity in normal and diabetic cats. J Feline Med Surg 1999;1:107-115.
6. Norsworthy GD. Recognizing and treating hypoglycemia in diabetic cats. Vet Med 1998;93:707-711.
7. Nelson RW, Feldman EC, Ford SL, et al. Effect of an orally administered sulfonylurea, glipizide, for treatment of diabetes mellitus in cats. J Am Vet Med Assoc 1993;203:821-827.
8. Feldman EC, Nelson RW, Feldman MS. Intensive 50-week evaluation of glipizide administration in 50 cats with previously untreated diabetes mellitus. J Am Vet Med Assoc 1997; 210:772-777.
9. Lamensdorf I, Eisenhofer G, Harvey-White J, et al. Effect of glipizide on dopamine synthesis, release and metabolism in PC12 cells. Eur J Pharmacol 2000;388:147-154.
10. Schmitz O, Lund S, Bak JF, et al. Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycemia in type 2 diabetic patients. Acta Diabetol 1994;31: 31-36.
11. Barzilai N, Groop PH, Groop L, et al. A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin. Acta Diabetol 1995;32:273-278.
12. Miller AB, Nelson RW, Kirk CA, et al. Effect of glipizide on serum insulin and glucose concentrations in healthy cats. Res Vet Sci 1992;52:177-181.
13. van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997;50:735-741.
14. Hoenig M, Hall G, Ferguson D, et al. A feline model of experimentally induced islet amyloidosis. Am J Pathol 2000;157: 2143-2150.
15. Papich MG. Drug compounding for veterinary patients. AAPS PharmSci 2005;in press.
16. Mealey KL, Peck KE, Bennett BS, et al. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats. J Vet Intern Med 2004;18:43-46.
17. Hoffman SB, Yoder AR, Trepanier LA. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther 2002;25:189-193.
18. Ciribassi J, Luescher A, Pasloske KS, et al. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats. Am J Vet Res 2003;64:994-998.
19. Glipizide tablet [official monograph]. USP 28/NF 23. Rockville, Md: US Pharmacopeia, 2005;903-904.
20. Hoenig M, Ferguson DC. Impairment of glucose tolerance in hyperthyroid cats. J Endocrinol 1989;121:249-251.
21. Wahlin-Boll E, Melander A. High-performance liquid chromatographic determination of glipizide and some other sulfonylurea drugs in serum. J Chromatogr 1979;164:541-546.
22. Emilsson H. High-performance liquid chromatographic determination of glipizide in human plasma and urine. J Chromatogr 1987;421:319-326.
23. Gabrielsson J, Weiner D. Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. 3rd ed. Apotekarsocieteten (Swedish Academy of Pharmaceutical Sciences), Stockholm, Sweden 2000;263.
24. Magnusson BM, Walters KA, Roberts MS. Veterinary drug delivery: potential for skin penetration enhancement. Adv Drug Deliv Rev 2001;50:229-244.
25. Langer R. Transdermal drug delivery: past progress, current status, and future prospects. Adv Drug Deliv Rev 2004;56:557-558.
26. Mitragotri S. Breaking the skin barrier. Adv Drug Deliv Rev 2004;56:555-556.
27. Finnin BC, Morgan TM. Transdermal penetration enhancers: applications, limitations, and potential. J Pharm Sci 1999; 88:955-958.
28. Monteiro-Riviere NA, Bristol DG, Manning TO, et al. Interspecies and interregional analysis of the comparative histologic thickness and laser Doppler blood flow measurements at five cutaneous sites in nine species. J Invest Dermatol 1990;95:582-586.
29. Lee CK, Uchida T, Kitagawa K, et al. Skin permeability of various drugs with different lipophilicity. J Pharm Sci 1994;83:562-565.
30. Dreher F, Walde P, Luisi PL, et al. Human skin irritation studies of a lecithin microemulsion gel and of lecithin liposomes. Skin Pharmacol 1996;9:124-129.
31. Pentikainen PJ, Neuvonen PJ, Penttila A. Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers. Int J Clin Pharmacol Ther Toxicol 1983;21:98-107.
32. Peterson CM, Sims RV, Jones RL, et al. Bioavailability of glipizide and its effect on blood glucose and insulin levels in patients with non-insulin-dependent diabetes. Diabetes Care 1982;5: 497-500.